Fortis Therapeutics
Focus: Fortis Therapeutics is a La Jolla-based biotech founded in 2021 specializing in antibody-drug conjugates (ADCs) across oncology, respiratory, cardiovascular, metabolic, and dermatology indications. As a publicly traded company, it operates at the early-stage clinical phase with a focused pipeline.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Fortis Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Fortis Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
15 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT02358967Palm Tocotrienols in Chronic Hemodialysis (USA)
N/AHelp build intelligence for Fortis Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.